These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 5121157)
1. New usage for an old drug in diabetic neuropathy. Value of amphetamines for symptomatic relief. Masor N J Natl Med Assoc; 1971 Sep; 63(5):380-3. PubMed ID: 5121157 [No Abstract] [Full Text] [Related]
2. A clinical trial of carbamazepine in the symptomatic treatment of diabetic peripheral neuropathy. Badran AM; Aly MA; Sous ES J Egypt Med Assoc; 1975; 58(11-12):627-31. PubMed ID: 1236490 [No Abstract] [Full Text] [Related]
3. Relief of severe diabetic truncal pain with mexiletine. Kubota K; Joshita Y; Tamura J; Ikeda M; Kurabayashi H; Kawada E; Okamoto K; Shirakura T J Med; 1991; 22(4-5):307-10. PubMed ID: 1838566 [TBL] [Abstract][Full Text] [Related]
4. [Management of diabetic neuropathy]. Hirose T Masui; 2010 Nov; 59(11):1378-84. PubMed ID: 21077305 [TBL] [Abstract][Full Text] [Related]
5. Trial of ganglioside therapy for diabetic neuropathy. Hallett M; Flood T; Slater N; Dambrosia J Muscle Nerve; 1987; 10(9):822-5. PubMed ID: 3683453 [TBL] [Abstract][Full Text] [Related]
7. Relief for pain of neuropathy. The anticonvulsant drug topiramate targets the underlying disease of diabetics. Health News; 2004 Oct; 10(10):14-5. PubMed ID: 15584125 [No Abstract] [Full Text] [Related]
8. An update on the treatment and management of diabetic peripheral neuropathy. Donnan J; Ledger S CANNT J; 2006; 16(4):32-6; quiz 37-8. PubMed ID: 17252899 [TBL] [Abstract][Full Text] [Related]
9. [Possibility of the use of cerebral gangliosides in the treatment of peripheral diabetic neuropathy]. Montenero P; Marozzi G; Chiaramonte F Clin Ter; 1983 Aug; 106(3):169-74. PubMed ID: 6627889 [No Abstract] [Full Text] [Related]
10. Painful diabetic peripheral neuropathy relieved with use of oral topiramate. Kline KM; Carroll DG; Malnar KF South Med J; 2003 Jun; 96(6):602-5. PubMed ID: 12938790 [TBL] [Abstract][Full Text] [Related]
11. A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. A preliminary report. Valensi P; Le Devehat C; Richard JL; Farez C; Khodabandehlou T; Rosenbloom RA; LeFante C J Diabetes Complications; 2005; 19(5):247-53. PubMed ID: 16112498 [TBL] [Abstract][Full Text] [Related]
12. Peripheral diabetic neuropathy treated with amitriptyline and fluphenazine. Davis JL; Lewis SB; Gerich JE; Kaplan RA; Schultz TA; Wallin JD JAMA; 1977 Nov; 238(21):2291-2. PubMed ID: 199754 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of diabetic neuropathy--with special reference to our cases]. Kito S; Kuboshima K; Yamamoto M; Fujimori N; Kosaka K Nihon Rinsho; 1971 Dec; 29(12):3026-33. PubMed ID: 5169017 [No Abstract] [Full Text] [Related]
14. Two new amphetamines for ADHD. Med Lett Drugs Ther; 2016 Jun; 58(1497):80-1. PubMed ID: 27305069 [No Abstract] [Full Text] [Related]
16. Choosing drugs for the treatment of diabetic neuropathy. Alabdali M; Qrimli M; Barnett C; Abraham A; Breiner A; Katzberg HD; Aljaafari D; Albulaihe H; Perkins BA; Bril V Expert Opin Pharmacother; 2015; 16(12):1805-14. PubMed ID: 26161591 [TBL] [Abstract][Full Text] [Related]
17. Treatment of diabetic neuropathy with diphenylhydantoin. Ellenberg M N Y State J Med; 1968 Oct; 68(20):2653-5. PubMed ID: 4300475 [No Abstract] [Full Text] [Related]
18. [Effects of prostaglandin El on severe diabetic neuropathy]. Kamio N; Ishihara H; Kondo T; Kobayashi I Horumon To Rinsho; 1983 Sep; 31(9):887-92. PubMed ID: 6685590 [No Abstract] [Full Text] [Related]
19. Guidelines in practice: treatment of painful diabetic neuropathy. Shenoy AM Continuum (Minneap Minn); 2012 Feb; 18(1):192-8. PubMed ID: 22810079 [TBL] [Abstract][Full Text] [Related]